There are statistically significant benefit of the dinova espec ba, sene osu cause mortality and other causes of mortality. But within the m r andaxcines, i cannot say that the effect against cobit was statistically sigcnificantly different from the effect against caduvascular disease. For that the numbers are too small. However for the overall differences in effect between the two groups of accines, there are statistical differences. Andd just as the the effect of the ednoviresectoaxcines various causes of death is also statistically significant.